Jiangsu Hengrui Medicine Co., Ltd.
Clinical trials sponsored by Jiangsu Hengrui Medicine Co., Ltd., explained in plain language.
-
New hope for hard-to-treat pancreatic cancer: targeted drug combo enters final testing phase
Disease control Not yet recruitingThis study tests whether adding the experimental drug HRS-4642 to standard chemotherapy helps people with advanced pancreatic cancer that has a specific KRAS G12D gene mutation. About 588 adults aged 18-75 with good performance status will be randomly assigned to receive either t…
Phase: PHASE3 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated Jun 12, 2026 12:03 UTC
-
Healthy volunteers to test new pill formula for future breast cancer treatment
Knowledge-focused Not yet recruitingThis early-stage study checks how a new formulation of the experimental drug HRS-6209 is absorbed in the body compared to the old version, and whether a high-fat meal changes absorption. It involves 21 healthy Chinese adults who take a single dose of the drug in three different s…
Phase: PHASE1 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 17, 2026 04:10 UTC